fbpx
Connect with us

CBD CONDITIONS & TREATMENTS

CBD Treatment Case: Stroke Recovery

Published

on

Stroke recovery is an interesting application of a cannabidiol (CBD) treatment regimen. In itself, a stroke is essentially the direct consequence of some sort of tear or blockage in an arterial point in the circulatory system with an endpoint in the brain.

The majority of strokes result from blockages while a small percentage are caused by tears. When we see this type of reduced blood flow, it is caused by some sort of clot or blockage in the bloodstream, we call this an ischemia. However, when there’s a tear, blood actually leaks into the cavity inside the cranium where the brain is housed, and that causes brain damage and destroys tissue that might otherwise not have been impacted by a simple clot.

In terms of causality, there are many different factors at work. A stroke has a lot in common with a heart attack. Both of these events are generally really about some sort of obstruction preventing proper flow in the circulatory system where critical organs such as the brain and heart are concerned.

Clogs, too much pressure, symptoms associated with diabetes, and ruptures in the circulatory system are all at work here, and can result in one of the two primary types of stroke: ischemic (blocked artery) and hemorrhagic (ruptured artery).

Diagnosis and Treatment

Generally speaking, diagnosis starts and ends with a physical exam by a trained physician based on basic symptoms. There is a timeline at work here as well, where symptoms are defined by how far away we are from the event at the time of the examination. Usually there is a question and answer process and personal medical history is taken into account.

Also included, often times, are processes such as blood tests, CT scans, and an MRI.

As noted above, there is a timeframe at work here that is extremely important. It is also important to determine which of the two major types of stroke is at work here after it has been determined that a stroke is part of the equation.

Treatments are often accomplished with clot-busting drugs, but these must start within 270 minutes following the actual event itself. The quickness of treatment is an enormous factor in determining long-term outcomes.

In addition, a physician will often order an intravenous injection of a tissue plasminogen activator (tPA). This substance has been shown to restore blood flow through the dissolution of clots in the circulatory system. This is the first step in attempting to manage a full recovery following a stroke.

For some patients, however, this drug is not safe to use, so this first step may be impacted by factors involved in the individual’s case.

Other steps can be involved as well, such as clot removing using a stent retriever, or other steps that are used in the case of a mini stroke. The fact is, the steps involved will vary widely depending upon the individual’s case.

CBD and Stroke

One of the key factors in the experience of a stroke is the triggering of the immune system. This is central to how the stroke ends up impacting the body over the long-term.

As we have covered extensively, CBD is highly effective in impacting the functionality of the immune system as a whole because of the endocannabinoid system’s large role in regulating the immune system in mammals. This is particularly true in terms of the crossover between the immune system and the brain, and one can see easily how this is central to the process of managing the symptoms following a stroke.

Crucially, CBD reduces oxidative stress, calcium buildup, and inflammation, which are essentially the three main causes of cell degeneration and destruction during and following a stroke.

As future research progresses from here, we will no doubt find more well substantiated proof of the role that CBD can play, and hopefully will become a more commonly used tool in managing poststroke symptomology and recovery.

Continue Reading
Advertisement

CBD CONDITIONS & TREATMENTS

CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million

Published

on

CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading

CBD CONDITIONS & TREATMENTS

Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group

Published

on

Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading

CBD CONDITIONS & TREATMENTS

Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida

Published

on

Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading
Advertisement
Advertisement
Advertisement






Trending Stories